Longitudinal association between markers of liver injury and mortality in COVID-19 in China

Hepatology

Association of liver abnormalities with in-hospital mortality in patients with COVID-19

J Hepatol

Ding ZY, Li GX, Chen L, Shu C, Song J, Wang W, Wang YW, Chen Q, Jin GN, Liu TT, Liang JN, Zhu P, Zhu W, Li Y, Zhang BH, Feng H, Zhang WG, Yin ZY, Yu WK, Yang Y, Zhang HQ, Tang ZP, Wang H, Hu JB, Liu JH, Yin P, Chen XP, Zhang B, Tongji Multidisciplinary Team for Treating COVID-19 (TTTC).

doi: 10.1016/j.jhep.2020.12.012

Hepatology

Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies

Hepatol Res.

Parohan M, Yaghoubi S, Seraj A

doi: 10.1111/hepr.13510.

Hepatology

Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort

Hepatology.

Phipps MM, Barraza LH, LaSota ED, Sobieszczyk ME, Pereira MR, Zheng EX, Fox AN, Zucker J, Verna EC

doi: 10.1002/hep.31404.

Hepatology

Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19

Gut.

Yip TC, Lui GC, Wong VW, Chow VC, Ho TH, Li TC, Tse YK, Hui DS, Chan HL, Wong GL

doi: 10.1136/gutjnl-2020-321726.

Further Publications

AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19

Gastroenterology.

Sultan S, Altayar O, Siddique SM, Davitkov P, Feuerstein JD, Lim JK, Falck-Ytter Y, El-Serag HB, AGA.

doi: 10.1053/j.gastro.2020.05.001.

Hepatology

Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients

J Gastroenterol Hepatol.

Gao F, Zheng KI, Wang XB, Yan HD, Sun QF, Pan KH, Wang TY, Chen YP, George J, Zheng MH

doi: 10.1111/jgh.15112.

Hepatology

Liver Biochemistries in Hospitalized Patients With COVID-19

Hepatology.

Bloom PP, Meyerowitz EA, Reinus Z, Daidone M, Gustafson J, Kim AY, Schaefer E, Chung RT

doi: 10.1002/hep.31326.

Hepatology

SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19

J Hepatol.

Wang Y, Liu S, Liu H, Li W, Lin F, Jiang L, Li X, Xu P, Zhang L, Zhao L, Cao Y, Kang J, Yang J, Li L, Liu X, Li Y, Nie R, Mu J, Lu F, Zhao S, Lu J, Zhao J

doi: 10.1016/j.jhep.2020.05.002.

Hepatology

High rates of 30-day mortality in patients with cirrhosis and COVID-19

J Hepatol.

Iavarone M, D'Ambrosio R, Soria A, Triolo M, Pugliese N, Del Poggio P, Perricone G, Massironi S, Spinetti A, Buscarini E, Viganò M, Carriero C, Fagiuoli S, Aghemo A, Belli LS, Lucà M, Pedaci M, Rimondi A, Rumi MG, Invernizzi P, Bonfanti P, Lampertico P

doi: 10.1016/j.jhep.2020.06.001.

Related content

Association of liver abnormalities with in-hospital mortality in patients with COVID-19

Liver injury is associated with severe Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of retrospective studies

Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort

Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19

AGA Institute Rapid Review of the GI and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19

Metabolic associated fatty liver disease increases COVID-19 disease severity in non-diabetic patients

Liver Biochemistries in Hospitalized Patients With COVID-19

SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19

High rates of 30-day mortality in patients with cirrhosis and COVID-19